⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for stage iii uterine corpus leiomyosarcoma ajcc v8

Every month we try and update this database with for stage iii uterine corpus leiomyosarcoma ajcc v8 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine LeiomyosarcomaNCT03880019
Stage III Uteri...
Stage IV Uterin...
Uterine Corpus ...
Computed Tomogr...
Core Biopsy
Magnetic Resona...
Olaparib
Temozolomide
18 Years - National Cancer Institute (NCI)
Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic SarcomaNCT02601209
High Grade Sarc...
Metastatic Leio...
Metastatic Mali...
Metastatic Syno...
Metastatic Undi...
Metastatic Unre...
Myxofibrosarcom...
Recurrent Leiom...
Recurrent Malig...
Recurrent Synov...
Recurrent Undif...
Stage III Uteri...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IV Uterin...
Stage IVA Uteri...
Stage IVB Uteri...
Unresectable Le...
Pazopanib
Pazopanib Hydro...
Sapanisertib
18 Years - National Cancer Institute (NCI)
Cabozantinib and Temozolomide for the Treatment of Unresectable or Metastatic Leiomyosarcoma or Other Soft Tissue SarcomaNCT04200443
Metastatic Leio...
Metastatic Soft...
Stage III Uteri...
Stage IIIA Uter...
Stage IIIB Uter...
Stage IIIC Uter...
Stage IV Uterin...
Stage IVA Uteri...
Stage IVB Uteri...
Unresectable Le...
Unresectable So...
Cabozantinib
Quality-of-Life...
Questionnaire A...
Temozolomide
18 Years - City of Hope Medical Center
Testing Olaparib and Temozolomide Versus the Usual Treatment for Uterine Leiomyosarcoma After Chemotherapy Has Stopped WorkingNCT05432791
Locally Advance...
Metastatic Uter...
Stage III Uteri...
Stage IV Uterin...
Unresectable Ut...
Biospecimen Col...
Bone Scan
Computed Tomogr...
Magnetic Resona...
Multigated Acqu...
Olaparib
Pazopanib
Temozolomide
Trabectedin
Transthoracic E...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: